News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
316,198 Results
Type
Article (11112)
Company Profile (127)
Press Release (304959)
Multimedia
Podcasts (16)
Webinars (7)
Section
Business (92989)
Career Advice (375)
Deals (16455)
Drug Delivery (43)
Drug Development (32156)
Employer Resources (61)
FDA (8662)
Job Trends (7894)
News (152768)
Policy (12585)
Tag
Academia (1264)
Accelerated approval (1)
Adcomms (1)
Allergies (45)
Alliances (28584)
ALS (48)
Alzheimer's disease (672)
Antibody-drug conjugate (ADC) (81)
Approvals (8763)
Artificial intelligence (209)
Autoimmune disease (11)
Automation (15)
Bankruptcy (111)
Best Places to Work (7079)
BIOSECURE Act (10)
Biosimilars (47)
Biotechnology (80)
Bladder cancer (50)
Brain cancer (17)
Breast cancer (164)
Cancer (1420)
Cardiovascular disease (110)
Career advice (332)
Career pathing (9)
CAR-T (94)
Cell therapy (275)
Cervical cancer (15)
Clinical research (27804)
Collaboration (684)
Company closure (1)
Compensation (158)
Complete response letters (5)
COVID-19 (818)
CRISPR (23)
C-suite (195)
Cystic fibrosis (42)
Data (1462)
Denatured (13)
Depression (24)
Diabetes (141)
Diagnostics (3470)
Digital health (12)
Diversity (1)
Diversity, equity & inclusion (21)
Drug discovery (74)
Drug pricing (57)
Drug shortages (4)
Duchenne muscular dystrophy (49)
Earnings (31410)
Editorial (10)
Employer branding (4)
Employer resources (54)
Events (47830)
Executive appointments (575)
FDA (9608)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (579)
Gene editing (53)
Generative AI (15)
Gene therapy (166)
GLP-1 (270)
Government (1567)
Grass and pollen (2)
Guidances (99)
Healthcare (9917)
Huntington's disease (6)
IgA nephropathy (17)
Immunology and inflammation (50)
Indications (27)
Infectious disease (893)
Inflammatory bowel disease (71)
Inflation Reduction Act (8)
Influenza (31)
Intellectual property (71)
Interviews (52)
IPO (6984)
IRA (28)
Job creations (1207)
Job search strategy (292)
Kidney cancer (7)
Labor market (13)
Layoffs (153)
Leadership (6)
Legal (2261)
Liver cancer (36)
Lung cancer (196)
Lymphoma (86)
Machine learning (7)
Management (21)
Manufacturing (229)
MASH (27)
Medical device (9187)
Medtech (9190)
Mergers & acquisitions (9910)
Metabolic disorders (308)
Multiple sclerosis (35)
NASH (2)
Neurodegenerative disease (37)
Neuropsychiatric disorders (6)
Neuroscience (963)
NextGen: Class of 2025 (3071)
Non-profit (2443)
Now hiring (4)
Obesity (136)
Opinion (106)
Ovarian cancer (54)
Pain (59)
Pancreatic cancer (48)
Parkinson's disease (88)
Partnered (17)
Patents (151)
Patient recruitment (81)
Peanut (22)
People (28914)
Pharmaceutical (36)
Pharmacy benefit managers (4)
Phase I (8802)
Phase II (11232)
Phase III (9854)
Pipeline (804)
Policy (66)
Postmarket research (949)
Preclinical (2709)
Press Release (48)
Prostate cancer (71)
Psychedelics (4)
Radiopharmaceuticals (201)
Rare diseases (182)
Real estate (2868)
Recruiting (23)
Regulatory (9880)
Reports (22)
Research institute (1258)
Resumes & cover letters (49)
Rett syndrome (5)
RSV (10)
Schizophrenia (42)
Series A (101)
Series B (74)
Service/supplier (8)
Sickle cell disease (22)
Special edition (3)
Spinal muscular atrophy (54)
Sponsored (14)
Startups (1942)
State (1)
Stomach cancer (3)
Supply chain (37)
Tariffs (24)
The Weekly (2)
Vaccines (240)
Venture capitalists (22)
Weight loss (64)
Women's health (20)
Worklife (7)
Date
Today (76)
Last 7 days (593)
Last 30 days (1959)
Last 365 days (19680)
2025 (7411)
2024 (20831)
2023 (22180)
2022 (27766)
2021 (28929)
2020 (27306)
2019 (25669)
2018 (19201)
2017 (16958)
2016 (15749)
2015 (17536)
2014 (12361)
2013 (9959)
2012 (10789)
2011 (10532)
2010 (8910)
Location
Africa (255)
Alabama (25)
Alaska (4)
Arizona (90)
Arkansas (11)
Asia (20753)
Australia (2811)
California (3255)
Canada (1199)
China (459)
Colorado (159)
Connecticut (189)
Delaware (99)
Europe (50556)
Florida (585)
Georgia (146)
Idaho (25)
Illinois (368)
India (17)
Indiana (247)
Iowa (9)
Japan (129)
Kansas (56)
Kentucky (9)
Louisiana (6)
Maine (27)
Maryland (525)
Massachusetts (2587)
Michigan (139)
Minnesota (238)
Mississippi (1)
Missouri (65)
Montana (23)
Nebraska (13)
Nevada (49)
New Hampshire (47)
New Jersey (1213)
New Mexico (19)
New York (1079)
North Carolina (595)
North Dakota (7)
Northern California (1355)
Ohio (132)
Oklahoma (11)
Oregon (21)
Pennsylvania (853)
Puerto Rico (5)
Rhode Island (23)
South America (417)
South Carolina (23)
South Dakota (1)
Southern California (1215)
Tennessee (80)
Texas (520)
United States (13685)
Utah (100)
Virginia (92)
Washington D.C. (39)
Washington State (292)
West Virginia (2)
Wisconsin (58)
316,198 Results for "max planck innovation gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Max Foundation (Max) Expands Collaboration with Novartis to Include Access to Innovative Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH)
December 6, 2024
·
3 min read
Press Releases
Okami Medical Announces Portfolio Expansion with the Addition of the SENDERO® MAX Delivery Catheter
March 25, 2025
·
2 min read
Press Releases
Synthego and Vita Therapeutics Announce Strategic Licensing Agreement for hfCas12Max CRISPR Nuclease
April 8, 2025
·
2 min read
Press Releases
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
April 22, 2025
·
6 min read
Press Releases
Swarm Oncology Ltd. and Cellex Cell Professionals GmbH Announce Strategic Partnership to Advance Swarm’s Innovative T Cell Therapies for Solid Cancers
February 25, 2025
·
3 min read
Press Releases
MAXONA PHARMACEUTICALS ANNOUNCES MAX-OO1 PHASE 1 CLINICAL PROGRAM RESULTS
March 19, 2025
·
5 min read
Press Releases
MAXONA PHARMACEUTICALS GRANTED FIFTH PATENT FOR FIRST TO MARKET PRODUCT MAX-001
February 26, 2025
·
3 min read
Press Releases
Metaba and MAX BioPharma Announce Breakthrough Progress on Next-Generation Oxysterol-Based Antibiotics
February 20, 2025
·
3 min read
BiondVax’s Strategic Research Collaboration with Max Planck and UMG: Significant progress towards development of innovative nanosized antibodies (NanoAbs) for therapeutic indications in addition to COVID-19
BiondVax Pharmaceuticals Ltd. provided encouraging updates related to the strategic research collaboration between BiondVax, the Max Planck Institute for Multidisciplinary Sciences, and the University Medical Center Göttingen towards the development of a pipeline of innovative alpaca–derived nanosized antibody therapies.
September 20, 2022
·
6 min read
Press Releases
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
March 19, 2025
·
1 min read
1 of 31,620
Next
